St. Jude Children’s Research Hospital shared a post on Facebook:
“St. Jude welcomed more than 120 on-site attendees from 61 countries, along with over 1,000 virtual participants, for the annual St. Jude Global Alliance Convening.
This gathering marks a defining moment, introducing a bold, focused format to inspire transformative conversations and strengthen strategies for the future.
In his opening remarks, James R. Downing, MD, president and CEO, emphasized the importance of using collaboration to produce meaningful impact for children worldwide.
“We must work together to go after those rare, incurable cancers and develop global clinical trials and carry out those trials.” Downing said. ”Ultimately our future is coming together as a community-this global convening-and tackling the most difficult cancers so we can change the outlook for every single child. Only by working together can we accomplish that.”
Since its founding in 2018, the St. Jude Global Alliance has connected over 400 member institutions worldwide, united by the goal of improving access to quality care and increasing survival rates. This year’s convening ensures each region and program has a voice in shaping future priorities, building stronger alignment across global efforts.
By prioritizing open dialogue and inclusive representation, the Alliance translates shared priorities into action across regions and disciplines.
Members engage in research, training and program development, helping to expand access to quality pediatric health care and strengthen care delivery worldwide. The progress achieved by the Alliance highlights the importance of collaboration in delivering real change.
Through ongoing partnerships and shared expertise, members are turning strategic intent into improved outcomes for children, regardless of geography.”
More posts about St. Jude Children’s Research Hospital and James R. Downing on OncoDaily.
